Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07855185
Starting soon Observational

Trapezius Oxygenation and Cervical Function in Chronic Neck Pain

NCT07855185 · tracked via the Priya Life Science Turkey tracker
Sponsor
Kirsehir Ahi Evran Universitesi
Phase
Observational
Started
2026-10-05
Last updated
2026-10-06

Condition(s) studied

Chronic Neck Pain

Study summary

The aim of this study is to investigate the relationship between trapezius muscle oxygenation and cervical range of motion, muscle strength, and disability in individuals with chronic neck pain.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 18-65 years. * Chronic neck pain lasting for at least 3 months. * Neck pain intensity of ≥3 on the Visual Analog Scale during activity. * Willingness to participate in the study. Exclusion Criteria: * Motor deficit in the upper extremities. * History of cervical or upper-extremity surgery. * Rheumatologic or neurologic disease. * Any musculoskeletal condition affecting upper-extremity function. * Cervical injection or other invasive procedure within the previous 6 months. * Cognitive impairment preventing understanding or performance of study assessments.

Primary outcome measure(s)

  • Trapezius Muscle Oxygen Saturation — First Day
    Trapezius muscle oxygen saturation will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise.
  • Trapezius Total Hemoglobin — First day
    Trapezius total hemoglobin will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise.

Trial sites (1)

FacilityCityRegionStatus
Kırşehir Ahi Evran University. Kırşehir Turkey (Türkiye)

More Kirsehir Ahi Evran Universitesi trials in Turkey

The 6-minute Pegboard and Ring Test in Overweight and Obese Individuals Recruiting
Biomarkers in Ankylosing Spondylitis Active, not recruiting
Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis Recruiting
Activities of Daily Living and Upper Extremity Exercise Capacity of Individuals with High Body Mass Index Recruiting
The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients Recruiting

Other trials for the same condition

Association Between Periodontal Disease and Chronic Neck Pain Recruiting
Masseter Muscle Thickness in Individuals With Chronic Neck Pain Starting soon
Kinesiophobia, Pain and Disability in Chronic Neck Pain Recruiting
The Effectiveness of the Polyvagal Theory in Chronic Neck Pain Enrolling by invitation
Cervical Medial Branch Block Versus Ipsilateral Cervical Erector Spinae Plane Block Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07855185 on ClinicalTrials.gov ↗ ← All trials in Turkey